Li Z, Tian Y
Oncol Rep. 2025; 53(3).
PMID: 39930817
PMC: 11783035.
DOI: 10.3892/or.2025.8868.
Shao W, Feng Y, Huang J, Li T, Gao S, Yang Y
Open Life Sci. 2024; 19(1):20220936.
PMID: 39119480
PMC: 11306965.
DOI: 10.1515/biol-2022-0936.
Mosca N, Alessio N, Di Paola A, Marrapodi M, Galderisi U, Russo A
J Biomed Sci. 2024; 31(1):59.
PMID: 38835012
PMC: 11151680.
DOI: 10.1186/s12929-024-01049-y.
Liao X, Wei R, Zhou J, Wu K, Li J
Front Mol Biosci. 2024; 11:1327459.
PMID: 38516191
PMC: 10955361.
DOI: 10.3389/fmolb.2024.1327459.
Zhang M, Wang X, Zhao J, Yan J, He X, Qin D
Mol Biotechnol. 2023; 66(9):2241-2253.
PMID: 37608076
PMC: 11424664.
DOI: 10.1007/s12033-023-00812-0.
Long non-coding RNAs modulate tumor microenvironment to promote metastasis: novel avenue for therapeutic intervention.
Baba S, Baba S, Mir R, Elfaki I, Algehainy N, Ullah M
Front Cell Dev Biol. 2023; 11:1164301.
PMID: 37384249
PMC: 10299194.
DOI: 10.3389/fcell.2023.1164301.
A glycometabolic gene signature associating with immune infiltration and chemosensitivity and predicting the prognosis of patients with osteosarcoma.
Wang F, Yang K, Pan R, Xiang Y, Xiong Z, Li P
Front Med (Lausanne). 2023; 10:1115759.
PMID: 37293295
PMC: 10244582.
DOI: 10.3389/fmed.2023.1115759.
A short peptide LINC00665_18aa encoded by lncRNA LINC00665 suppresses the proliferation and migration of osteosarcoma cells through the regulation of the CREB1/RPS6KA3 interaction.
Pan J, Liu M, Duan X, Wang D
PLoS One. 2023; 18(6):e0286422.
PMID: 37285335
PMC: 10246827.
DOI: 10.1371/journal.pone.0286422.
Metastasis-Related Signature for Clinically Predicting Prognosis and Tumor Immune Microenvironment of Osteosarcoma Patients.
Zhang Q, Deng Z, Yang Y
Mol Biotechnol. 2023; 65(11):1836-1845.
PMID: 36807122
PMC: 10518285.
DOI: 10.1007/s12033-023-00681-7.
Exosomes from high glucose-treated macrophages promote epithelial-mesenchymal transition of renal tubular epithelial cells via long non-coding RNAs.
Yang H, Bai Y, Fu C, Liu W, Diao Z
BMC Nephrol. 2023; 24(1):24.
PMID: 36717805
PMC: 9887774.
DOI: 10.1186/s12882-023-03065-w.
The regulatory mechanism of LncRNA-mediated ceRNA network in osteosarcoma.
Lin C, Miao J, He J, Feng W, Chen X, Jiang X
Sci Rep. 2022; 12(1):8756.
PMID: 35610231
PMC: 9130241.
DOI: 10.1038/s41598-022-11371-w.
The Roles of Noncoding RNAs in the Development of Osteosarcoma Stem Cells and Potential Therapeutic Targets.
Liu J, Shang G
Front Cell Dev Biol. 2022; 10:773038.
PMID: 35252166
PMC: 8888953.
DOI: 10.3389/fcell.2022.773038.
Long noncoding RNA UCA1 facilitates cell proliferation and inhibits apoptosis in retinoblastoma by activating the PI3K/Akt pathway.
Yuan Z, Li Z
Transl Cancer Res. 2022; 9(2):1012-1022.
PMID: 35117446
PMC: 8798070.
DOI: 10.21037/tcr.2019.12.47.
MiR-654-3p Constrains Proliferation, Invasion, and Migration of Sinonasal Squamous Cell Carcinoma CREB1/PSEN1 Regulatory Axis.
Cui X, Yang Y, Yan A
Front Genet. 2022; 12:799933.
PMID: 35096015
PMC: 8791623.
DOI: 10.3389/fgene.2021.799933.
Regulatory role of long non-coding RNA UCA1 in signaling pathways and its clinical applications.
Liu Z, Wang Y, Yuan S, Wen F, Liu J, Zou L
Oncol Lett. 2021; 21(5):404.
PMID: 33777227
PMC: 7988699.
DOI: 10.3892/ol.2021.12665.
Research progress regarding the role of long non-coding RNAs in osteosarcoma.
Zhang Y, Pu Y, Wang J, Li Z, Wang H
Oncol Lett. 2020; 20(3):2606-2612.
PMID: 32782578
PMC: 7400499.
DOI: 10.3892/ol.2020.11807.
Knockdown of KRT17 decreases osteosarcoma cell proliferation and the Warburg effect via the AKT/mTOR/HIF1α pathway.
Yan X, Yang C, Hu W, Chen T, Wang Q, Pan F
Oncol Rep. 2020; 44(1):103-114.
PMID: 32627037
PMC: 7251737.
DOI: 10.3892/or.2020.7611.
The Gαh/phospholipase C-δ1 interaction promotes autophagosome degradation by activating the Akt/mTORC1 pathway in metastatic triple-negative breast cancer.
Lin H, Kuei C, Lee H, Lin C, Zheng J, Chiu H
Aging (Albany NY). 2020; 12(13):13023-13037.
PMID: 32615541
PMC: 7377847.
DOI: 10.18632/aging.103390.
LAIR-1 overexpression inhibits epithelial-mesenchymal transition in osteosarcoma via GLUT1-related energy metabolism.
Zhang J, Zhang Y, Cheng S, Mu Y, Liu Y, Yi X
World J Surg Oncol. 2020; 18(1):136.
PMID: 32563267
PMC: 7345510.
DOI: 10.1186/s12957-020-01896-7.
Suppression of CLEC3A inhibits osteosarcoma cell proliferation and promotes their chemosensitivity through the AKT1/mTOR/HIF1α signaling pathway.
Ren C, Pan R, Hou L, Wu H, Sun J, Zhang W
Mol Med Rep. 2020; 21(4):1739-1748.
PMID: 32319617
PMC: 7057774.
DOI: 10.3892/mmr.2020.10986.